홈 › 급성 이표형 백혈병 › 캘리포니아
캘리포니아의 급성 이표형 백혈병 임상 시험
급성 이표형 백혈병 관련 연구 15개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.
캘리포니아의 도시
- Baldwin Park연구 6개
- Los Angeles연구 6개
- San Diego연구 5개
- San Francisco연구 5개
- Mountain View연구 4개
- Orange연구 4개
- Sacramento연구 3개
- Long Beach연구 3개
- Oakland연구 3개
- San Bernardino연구 3개
공식 연구 텍스트(영어)
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- City of Hope, Duarte
- UC Davis, Sacramento
- Stanford Health Care, Stanford
피험자 모집 중1상
12세 ~ 78세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT03802695Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- UCSF Benioff Children's Hospital Oakland, Oakland
- 외 4개
피험자 모집 중2상
365 Days · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06317662Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Kaiser Permanente Downey Medical Center, Downey
- City of Hope Comprehensive Cancer Center, Duarte
- Loma Linda University Medical Center, Loma Linda
- 외 14개
피험자 모집 중3상
365 Days – 25 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT03959085The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Kaiser Permanente Downey Medical Center, Downey
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- 외 8개
피험자 모집 중1/2상
22세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04726241Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
- Rady Children's Hospital, San Diego
피험자 모집 중2상
1세 ~ 18세 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT06390319Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- City of Hope, Duarte
- Valkyrie Clinical Trials, Los Angeles
피험자 모집 중1/2상
13세 ~ 90세 · 모든 성별 · 2026. 8. 6. 업데이트됨 · NCT06533579Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
- Rady Children's Hospital, San Diego
피험자 모집 중1상
1세 ~ 30세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06177067Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- Rady Children's Hospital, San Diego
피험자 모집 중4상
1세 ~ 18세 · 모든 성별 · 2026. 7. 14. 업데이트됨 · NCT06289673Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- UCLA Department of Medicine, Los Angeles
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT07216443Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
- Stanford University, Palo Alto
피험자 모집 중1상
18세 ~ 70세 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT06551584A Study of Revumenib and Mezigdomide in People With Leukemia
- City of Hope Cancer Center (Data collection only), Duarte
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 6. 22. 업데이트됨 · NCT07356154The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- City of Hope, Duarte
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
- 외 1개
피험자 모집 중1/2상
12세 ~ 95세 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT04329728Venetoclax Basket Trial for High Risk Hematologic Malignancies
- University of California San Francisco-Benioff Children's Hospital, San Francisco
피험자 모집 중1상
1세 ~ 40세 · 모든 성별 · 2026. 3. 12. 업데이트됨 · NCT05292664Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
- City of Hope Medical Center, Duarte
피험자 모집 중1상
2세 이상 · 모든 성별 · 2026. 3. 5. 업데이트됨 · NCT06575296Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital Los Angeles, Los Angeles
- Children's Hospital Orange County, Orange
- UCSF School of Medicine, San Francisco
피험자 모집 중1상
1세 ~ 21세 · 모든 성별 · 2024. 12. 6. 업데이트됨 · NCT05476770ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.